|
⚲
|
| Keyboard |
| Kearns Evan
✚
|
|
|---|---|
| CIK # | 0001745285 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001745285] | |
| 4 | [0001745285] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cogent Biosciences Inc | |
| Kearns Evan | |
| Agenus Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cogent Biosciences Inc COGT
Common Stock
|
2025-12-26 | Sell | 65,000 | $38.70 | 2,515,500 |
|
Cogent Biosciences Inc COGT
Stock Option (Right to Buy) · derivative
|
2025-12-17 | Grant | 55,000 | $0.00 | |
|
Cogent Biosciences Inc COGT
Common Stock
|
2025-12-17 | Grant | 40,000 | $0.00 | |
|
Cogent Biosciences Inc COGT
Common Stock
|
2025-12-17 | Grant | 260,000 | $0.00 | |
|
Cogent Biosciences Inc COGT
Common Stock
|
2025-12-17 | Tax withheld | 125,602 | $39.45 | 4,954,999 |
|
Cogent Biosciences Inc COGT
Stock Option (Right to Buy) · derivative
|
2025-01-23 | Grant | 230,000 | $0.00 | |
|
Cogent Biosciences Inc COGT
Stock Option (Right to Buy) · derivative
|
2024-01-23 | Grant | 255,000 | $0.00 | |
|
Cogent Biosciences Inc COGT
Stock Option (Right to Buy) · derivative
|
2023-02-13 | Grant | 140,000 | $0.00 | |
|
Cogent Biosciences Inc COGT
Stock Option (Right to Buy) · derivative
|
2022-01-25 | Grant | 202,250 | $4.94 | 999,115 |
|
Cogent Biosciences Inc COGT
Stock Option (Right to Buy) · derivative
|
2021-05-03 | Grant | 260,000 | $0.00 | |
|
Agenus Inc AGEN
Stock Option (Right to buy) · derivative
|
2020-12-17 | Grant | 150,000 | $0.00 | |
|
Agenus Inc AGEN
Stock Option (Right to buy) · derivative
|
2019-12-24 | Grant | 300,000 | $0.00 | |
|
Agenus Inc AGEN
Stock Option (Right to buy) · derivative
|
2019-07-23 | Grant | 18,333 | $0.00 | |
|
Agenus Inc AGEN
Stock Option(right to buy) · derivative
|
2019-06-19 | Grant | 200,000 | $0.00 |